Martin Sanabria

Deputy Director Hematology
Bayer, Basel, Switzerland

Presentation(s):

• PB1123 - Annualised Bleeding Rate and Joint Health: Second Interim Analysis of the Real-world HEM-POWR Study Evaluating the Effectiveness of Damoctocog Alfa Pegol in Patients With Haemophilia A

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM